Back
Novo Nordisk AS Vs. Nutanix Industry Stock Comparison
Sell
25
NVO
Novo Nordisk AS
Last Price:
$88.08
Seasonality Move:
3.64%
Buy
56
NTNX
Nutanix
Last Price:
$69.75
Seasonality Move:
-8.12%
Sell
25
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $88.08. The Score for NVO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $88.08The current trend is relatively stagnant and NVO is experiencing slight buying pressure.
NTNX Stock Price Chart
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.13 | Sell |
Relative Strength Index (14 RSI): | 56.29 | Buy |
Chaikin Money Flow: | 5125093 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (80.7 - 86.28) | Buy |
Bollinger Bands (100): | (86.25 - 113.99) | Sell |
NTNX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.48 | Buy |
Relative Strength Index (14 RSI): | 52.7 | Buy |
Chaikin Money Flow: | -1070078 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (66.23 - 71.61) | Buy |
Bollinger Bands (100): | (61.98 - 69.78) | Buy |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 82.47 | Buy |
20-day SMA: | 84.14 | Buy |
50-day SMA: | 88.64 | Sell |
200-day SMA: | 117.58 | Sell |
8-day EMA: | 83.79 | Buy |
20-day EMA: | 84.03 | Buy |
50-day EMA: | 89.2 | Sell |
200-day EMA: | 106.93 | Sell |
NTNX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 71.16 | Sell |
20-day SMA: | 69.71 | Buy |
50-day SMA: | 66.42 | Buy |
200-day SMA: | 61.49 | Buy |
8-day EMA: | 70.99 | Sell |
20-day EMA: | 69.74 | Buy |
50-day EMA: | 67.65 | Buy |
200-day EMA: | 61.78 | Buy |
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and an increase next year of $0.86 per share.
Nutanix Earnings Growth & NTNX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.10 per share, an increase this year of $0.28 per share, and an increase next year of $0.36 per share.
Novo Nordisk AS Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nutanix Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |